Tenet Reports Results for the Third Quarter Ended September 30, 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Tenet Healthcare (THC) PT Raised to $33 at Mizuho Securities
November 5, 2019 11:59 AM ESTMizuho Securities analyst Ann Hynes raised the price target on Tenet Healthcare (NYSE: THC) to $33.00 (from $30.00) while maintaining a Buy rating.
The analyst commented, "We are raising our price target on THC to $33 (from $30) post a solid 3Q:19. Volume growth accelerated... More
Tenet Healthcare (THC) Tops Q3 EPS by 28c, Offers Q4 Guidance
November 4, 2019 4:21 PM ESTTenet Healthcare (NYSE: THC) reported Q3 EPS of $0.58, $0.28 better than the analyst estimate of $0.30. Revenue for the quarter came in at $4.57 billion versus the consensus estimate of $4.46 billion.
GUIDANCE:
Tenet Healthcare sees Q4 2019 EPS of $0.57-$1.23, versus the consensus of $1.00.... More
